Bright Minds Biosciences ...

NASDAQ: DRUG · Real-Time Price · USD
41.80
-0.74 (-1.74%)
At close: Aug 15, 2025, 3:59 PM
43.00
2.86%
After-hours: Aug 15, 2025, 05:39 PM EDT

Bright Minds Biosciences Cash Flow Statement

Financials in CAD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-2.8M -7.37M -14.96M -8.65M
Depreciation & Amortization
73.36K 72.45K 6.04K n/a
Stock-Based Compensation
839.77K 1.15M 875.06K 880.62K
Other Working Capital
39.81K -941.72K 771.94K 416.23K
Other Non-Cash Items
-1.18K 65.1K -229.57K 144.76K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
39.81K -941.72K 726.31K 306.08K
Operating Cash Flow
-1.85M -7.02M -13.59M -7.32M
Capital Expenditures
n/a 5.00 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
-89.73K -86.11K -7.16K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
302.00 1.06M 1.17M -1.69M
Financial Cash Flow
810.57K 2.19M 5.2M 26.06M
Net Cash Flow
-1.03M -4.88M -8.13M 18.96M
Free Cash Flow
-1.85M -7.02M -13.59M -7.32M